MA29015B1 - Agents de liaison specifiques de l'angiopoietine-2 - Google Patents

Agents de liaison specifiques de l'angiopoietine-2

Info

Publication number
MA29015B1
MA29015B1 MA29892A MA29892A MA29015B1 MA 29015 B1 MA29015 B1 MA 29015B1 MA 29892 A MA29892 A MA 29892A MA 29892 A MA29892 A MA 29892A MA 29015 B1 MA29015 B1 MA 29015B1
Authority
MA
Morocco
Prior art keywords
angiopoietin
specific binding
binding agents
agents
specific
Prior art date
Application number
MA29892A
Other languages
English (en)
French (fr)
Inventor
Jonathon Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MA29015B1 publication Critical patent/MA29015B1/fr

Links

MA29892A 2004-10-19 2007-05-11 Agents de liaison specifiques de l'angiopoietine-2 MA29015B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
MA29015B1 true MA29015B1 (fr) 2007-11-01

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29892A MA29015B1 (fr) 2004-10-19 2007-05-11 Agents de liaison specifiques de l'angiopoietine-2

Country Status (10)

Country Link
JP (2) JP2008520188A (enrdf_load_stackoverflow)
CN (1) CN101495513B (enrdf_load_stackoverflow)
BR (1) BRPI0518209A (enrdf_load_stackoverflow)
EA (1) EA011866B1 (enrdf_load_stackoverflow)
IL (1) IL182279A0 (enrdf_load_stackoverflow)
MA (1) MA29015B1 (enrdf_load_stackoverflow)
MX (1) MX2007004247A (enrdf_load_stackoverflow)
RU (2) RU2404992C2 (enrdf_load_stackoverflow)
SG (1) SG156668A1 (enrdf_load_stackoverflow)
ZA (1) ZA200704020B (enrdf_load_stackoverflow)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011866B1 (ru) * 2004-10-19 2009-06-30 Амджен Инк. Агенты, специфически связывающие ангиопоэтин-2
JO3182B1 (ar) * 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
EA022546B1 (ru) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Способ торможения роста карциномы эрлиха у лабораторного животного
JP2014532053A (ja) * 2011-09-30 2014-12-04 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 治療用ペプチド
NZ627859A (en) * 2012-01-23 2015-09-25 Regeneron Pharma Stabilized formulations containing anti-ang2 antibodies
WO2014100834A1 (en) * 2012-12-21 2014-06-26 The Regents Of The University Of California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
CN105264380B (zh) 2013-05-14 2017-09-05 卫材R&D管理有限公司 用于预测和评价子宫内膜癌受试者对乐伐替尼化合物响应性的生物标志
AR100270A1 (es) * 2014-05-19 2016-09-21 Lilly Co Eli Anticuerpos ang2
AU2015309862C1 (en) 2014-08-28 2020-10-15 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
DK3263106T3 (da) 2015-02-25 2024-01-08 Eisai R&D Man Co Ltd Fremgangsmåde til undertrykkelse af bitterhed af quinolinderivat
KR20240064733A (ko) 2015-03-04 2024-05-13 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
MX381976B (es) 2015-08-20 2025-03-13 Eisai R&D Man Co Ltd Agente terapéutico contra tumores.
CN106512006A (zh) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用
CN106075448A (zh) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用
ES2971448T3 (es) 2017-02-08 2024-06-05 Eisai R&D Man Co Ltd Composición farmacéutica para el tratamiento de tumores
SG11201910100PA (en) 2017-05-16 2019-11-28 Eisai R&D Man Co Ltd Treatment of hepatocellular carcinoma
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
EP3932946A4 (en) * 2019-02-25 2023-03-22 Pharmabcine Inc. ANTI-ANG2 ANTIBODIES AND ITS USE
CN112126671B (zh) * 2020-08-18 2021-08-31 中山大学附属第五医院 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
CN116265487B (zh) * 2021-12-16 2025-01-10 三优生物医药(上海)有限公司 抗ang2-vegf双特异性抗体及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165115B1 (en) * 1999-03-26 2003-05-28 Regeneron Pharmaceuticals, Inc. Modulation of vascular permeability by mean of tie2 receptor activators
WO2000064946A2 (en) * 1999-04-28 2000-11-02 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting vegf
EE200200706A (et) * 2000-06-23 2004-06-15 Schering Aktiengesellschaft VEGF-i/VEGF-retseptori ja angiopoetiini/Tie-retseptori funktsiooni mõjustavad kombinatsioonid ja kompositsioonid ning nende kasutamine (II)
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
ATE536868T1 (de) * 2001-10-12 2011-12-15 Monosolrx Llc Einheitliche filme als schnell auflösende verabreichungsformen enthaltend geschmacksmaskiereden stoff
EA011866B1 (ru) * 2004-10-19 2009-06-30 Амджен Инк. Агенты, специфически связывающие ангиопоэтин-2

Also Published As

Publication number Publication date
IL182279A0 (en) 2007-07-24
EA200700876A1 (ru) 2007-10-26
SG156668A1 (en) 2009-11-26
JP2011207882A (ja) 2011-10-20
CN101495513A (zh) 2009-07-29
CN101495513B (zh) 2014-08-06
RU2404992C2 (ru) 2010-11-27
EA011866B1 (ru) 2009-06-30
ZA200704020B (en) 2008-06-25
RU2007118670A (ru) 2008-12-27
RU2010132956A (ru) 2012-02-10
BRPI0518209A (pt) 2008-11-04
JP2008520188A (ja) 2008-06-19
MX2007004247A (es) 2007-06-12

Similar Documents

Publication Publication Date Title
MA29015B1 (fr) Agents de liaison specifiques de l'angiopoietine-2
NO20041907L (no) Angiopoietin-2 spesifikke bindinsmidler
EP1819385A4 (en) NEEDLE ACQUISITION MECHANISMS
EP1771786A4 (en) SAMPLE PROCESSING SIMULTANEOUS
EP1789709A4 (en) STOPCOCK
EP1896040A4 (en) Phosphoramidate alkylator PRODRUGS
EP1937825A4 (en) MODIFIED 4'-NUCLEOSIDES AS ANTIVIRUS
EP1746141A4 (en) THICKENER
EP1924684A4 (en) Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
EP1827473A4 (en) MODULATOR OF ALPHA SYNNUCLEINE TOXICITY
FR2871145B1 (fr) Distributeur d'applicateurs
GB0307671D0 (en) Improvements relating to the construction of playing surfaces
DE60134988D1 (de) Verknüpfbare elastomerzusammensetzung
FR2875398B1 (fr) Implant articulaire d'interposition
EP1714656A4 (en) ED-71 preparation
EP1741218A4 (en) IMPROVED EXTENSION MOBILITY
FR2879635B1 (fr) Connecteur d'ossature
IL190045A0 (en) Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents
EP1704857A4 (en) ABCA1 STABILISATOR
FR2879109B1 (fr) Composition absorbante d'humidite
FR2880793B1 (fr) Prothese d'epaule
EP1819722A4 (en) MODULATION OF OVULATION
GB2409587B (en) 'Kwicap'
GB0510474D0 (en) Q's vaginometer
EP1756276A4 (en) KRUST ANIMAL EXPRESSION VECTOR